Skip to content
GLP-1 Decoder

Wegovy Kidney: How Common, How Long It Lasts, What Helps

The Wegovy label names acute kidney injury as a reported side effect but gives no trial rate for it.

In the label
Listed, no rate given
Label term
acute kidney injury

A quick look at Wegovy

How long it remains in the body
100%50%25%0%07 d14 d21 d28 d35 d50%25%12.5%time after the dose

Its half-life is about 1 week: after 7 d, half is gone, and five half-lives (35 d) leave about 3%.

Weight loss during the main trial
Wegovy (STEP 1)14.9%Placebo2.4%

For STEP 1 at 68 weeks, results showed 14.9% of body weight, compared with 2.4% on placebo.

Prices as time goes on
202520262027$1,349.02$0List priceSelf-pay

Monthly prices in US dollars cover the list price and self-pay offers, with each figure taken from the maker's price page.

Sources: FDA label (DailyMed), healthsystemtracker.org, prnewswire.com 1 2.

What the Wegovy label lists instead

No rate for kidney problems appears in the Wegovy label. The label lists five side effects most often and gives a rate for each one.

Table 3. Adverse Reactions (≥2% and Greater Than Placebo): WEGOVY 2.4 mg in Injection-treated Adults with Obesity or Overweight for Weight Reduction
Side effectPlaceboWegovy 2.4 mgMore than placebo
Nausea16%44%+28 points
Diarrhea16%30%+14 points
Vomiting6%24%+18 points
Constipation11%24%+13 points
Abdominal Pain10%20%+10 points

Source: the Wegovy label (DailyMed).

Source: FDA DailyMed label.

What the Wegovy label says

Here are the label's exact words about kidney problems:

“Acute kidney injury occurred in clinical trials for weight reduction in 7 adult patients (0.4 cases per 100 patient years) receiving WEGOVY versus 4 patients”

Source: FDA DailyMed label.